Patients undergoing transcatheter aortic valve implantation (TAVI) have distinctive characteristics: they are old, frail, with several co-morbidities and take multiple medications. Hemodynamic instability, cerebral embolism, sedation, general anesthesia and hospitalization in intensive care expose those patients to postprocedural delirium. Acute neurocognitive dysfunctions are associated with adverse outcomes in these population. The objective of this study is to determine the incidence of delirium and neurocognitive disorders in elderly patients after TAVI.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Enrollment
201
During the first post-procedural five days all patients will be evaluated on a daily basis for delirium occurrence by the CAM (Confusion Assessment Method) or CAM - ICU (Confusion Assessment Method - Intensive Care Unit)
Cardiocentro Ticino
Lugano, Canton Ticino, Switzerland
Incidence of delirium
The primary outcome is incidence of delirium. Delirium screening will be carry out using the CAM or CAM-ICU in accordance with local hospital clinical delirium-screening guidelines. The assessment of presence of Delirium will be perform by clinician with CAM in agreement with Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM IV). CAM is standardized method to enable non-psychiatrically trained clinicians to identify delirium and assesses nine features of delirium: (1) acute onset, (2) inattention, (3) disorganized thinking, (4) altered level of consciousness, (5) disorientation, (6) memory impairment, (7) perceptual disturbances, (8) psychomotor agitation or retardation and (9) altered sleep-wake cycle. Delirium is diagnosed when feature 1 and 2 are present and either 3 or 4 are displayed.
Time frame: Day 1-5 after transcatheter aortic valve implantation
Risk factors for postoperative delirium
Association between incidence of delirium and patient vulnerabilities, exposure to noxious or precipitating factors. The risk factors will be divided in pre-procedural, intra-procedural and post-procedural
Time frame: Baseline, intra-operative and days 1-5 after transcatheter aortic valve implantation
Onset of delirium
Time frame: Day 1-5 after transcatheter aortic valve implantation
Complications of delirium
Complications delirium related
Time frame: Day 1-5 after transcatheter aortic valve implantation
Type of delirium
Delirium classification according to Delirium Motor Subtype Scale (DMSS-4)
Time frame: Day 1-5 after transcatheter aortic valve implantation
Trajectories of neurocognitive function
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Regional cerebral oxygen saturation monitoring during TAVI procedure
Change of Mini-Mental State Examination (MMSE)
Time frame: Changes from baseline up to 5 day and 3-months
Trajectories of functional abilities
Change of Barthel Index (for Activities of Daily Living, ADL)
Time frame: Changes from baseline up to 5 day and 3-months
Mortality
Postoperative survival
Time frame: 30-days, 3-months and 1 year